AQST
Aquestive Therapeutics Inc
4.70$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -301.2% | -340.9% | -15.8% | 8.7% | -19.3% | -114.4% | -99.1% | -64.9% | -20.5% | -12.6% | -62.1% | -117.7% | |
| 33.7% | 63.7% | 7.5% | 5.7% | 4.8% | 5.5% | 7.5% | 5.8% | 5.0% | 2.7% | 1.2% | 1.2% | |
| – | – | – | – | 44.4% | 13.4% | 14.4% | 13.4% | 9.2% | 5.3% | 12.3% | 17.1% | |
| 36.4% | 45.9% | 10.1% | 5.4% | 52.4% | 23.4% | 14.8% | 40.0% | – | – | – | – | |
| – | – | -12.2% | 11.8% | 11.9% | -21.1% | -9.6% | -3.4% | 67.1% | -10.6% | -17.3% | 27.4% | |
| 130.1% | 124.4% | 1.9% | 3.1% | 2.7% | 1.3% | 1.1% | 1.8% | 5.3% | 2.0% | 0.3% | 1.3% | |
| -130.1% | -123.8% | 0.4% | -3.1% | -2.7% | -1.3% | -1.1% | -1.8% | -5.3% | -2.0% | -0.3% | -1.3% | |
| – | – | – | – | – | 5.4% | 0.2% | – | 0.0% | – | – | – | |
| 1.1% | 622.0% | 0.0% | 0.0% | 102.1% | -5.4% | -0.2% | 0.0% | 0.0% | 0.0% | – | – | |
| 481.5% | 355.5% | 14.5% | 7.5% | -7.1% | 24.9% | 48.7% | 0.0% | -4.2% | -44.5% | 0.0% | -0.1% | |
| 481.5% | 977.5% | 11.0% | 6.6% | 86.1% | 94.3% | 62.1% | 59.2% | 24.2% | 7.9% | 145.2% | 230.4% | |
| 50.2% | 512.9% | -4.4% | 12.2% | 64.1% | -21.4% | -38.2% | -7.4% | -1.6% | -6.7% | 82.8% | 111.4% | |
| – | – | -17.7% | 5.6% | -22.0% | -115.7% | -100.3% | -66.7% | -25.8% | -14.6% | -62.4% | -119.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.